Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

PDF

2010

Depression

Faculty of Health and Behavioural Sciences - Papers (Archive)

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

Do Pregnant Women And Those At Risk Of Developing Post-Natal Depression Consume Lower Amounts Of Long Chain Omega-3 Polyunsaturated Fatty Acids?, Victoria F. Cosatto, Paul L. Else, Barbara J. Meyer Jan 2010

Do Pregnant Women And Those At Risk Of Developing Post-Natal Depression Consume Lower Amounts Of Long Chain Omega-3 Polyunsaturated Fatty Acids?, Victoria F. Cosatto, Paul L. Else, Barbara J. Meyer

Faculty of Health and Behavioural Sciences - Papers (Archive)

The aims were to compare intakes of long chain omega-3 polyunsaturated fatty acid (LC n-3 PUFA) in pregnant and non-pregnant women in Australia and to compare these intakes to the Australian National Nutrition Survey of 1995 (NNS95) [1] and to determine if the LC n-3 PUFA intakes differed in women who may be ‘at risk’ compared with women ‘not at risk’ of developing post-natal depression (PND). A validated LC n-3 PUFA food frequency questionnaire and pregnant women’s Edinburgh Postnatal Depression Scale (EPDS) scores were used. LC n-3 PUFA intakes were comparable to the NNS95 but did not differ due to …


Ecstasy (Mdma) And Its Relationship With Self Report Depression, Anxiety And Schizotypy, Lisa Woods, Emma Barkus Jan 2010

Ecstasy (Mdma) And Its Relationship With Self Report Depression, Anxiety And Schizotypy, Lisa Woods, Emma Barkus

Faculty of Health and Behavioural Sciences - Papers (Archive)

Abstract. Aims: The relationship between ecstasy and affective psychological symptoms are still subject to debate. We aimed to examine the relationship between Ecstasy use and self-report depression, anxiety and schizotypy. Design: Data were collected via structured remote self-report questionnaires. Participants: Participants were split into three groups: a control group with no ecstasy use, a light ecstasy user group (<50 >times), and a heavy ecstasy user group (>50 times). Measurements: Amount and patterns of ecstasy use were recorded, the Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI) measured depression and anxiety respectively, and schizotypal traits were measured using the …